Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug - Global and China Top Players Market Share and Ranking 2024
- Report Code : AMP2755936
- Published On: Jul, 2024
- Category : Healthcare & Pharma
- Pages : 131
-
According to Ample Market Research, the global market for Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By segment, Hospital grew percent to account for percent of the total market sales, and Specialist Clinic grew percent.
Methicillin-resistant Staphylococcus aureus (MRSA) is a common bacterial infection pathogen that is more difficult to treat due to its resistance to conventional antibiotics such as methicillin. The most commonly used and most effective antibiotics are vancomycin, norvancomycin, and teicoplanin. Secondly, for patients with contraindications or intolerance of the above drugs, other antibacterial drugs, such as sodium fusidate, can also be used. In some countries and regions, ceftazidime, tigecycline, linezolid, daptomycin, etc. can also be used, all of which have good curative effects.
This report studies and analyses global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug status and future trends, helps the client to determine the Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug market size, history data 2019-2024, and forecast data 2024 -2030, (US$ million) & (K Units)
(2) Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug sales, revenue, price by company, market share and industry ranking 2019-2024, (US$ million) & (K Units)
(3) China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug sales, revenue, price by company, market share and industry ranking 2019-2024, (US$ million) & (K Units)
(4) Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug key producing regions, capacity, production, and year over year growth
(6) Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Basilea Pharmaceutica Ltd
The Medicines Company
Theravance Biopharma
Allergan
Merck & Co., Inc
Pfizer, Inc
Market segment by Type, covers
Lipopeptide
Oxazolidinone
Tetracycline
Cephalosporin
Lipoglycopeptide
Folate Antagonist
Other
Market segment by Application, can be divided into
Hospital
Specialist Clinic
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2019-2024
Chapter 3: China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2019-2024
Chapter 4: Global key producing regions of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug, percent & CAGR, 2019-2030
Chapter 5: Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
-
With tables and figures helping analyze worldwide Methicillin Resistant Staphylococcus Aureus Infection Treatment Drug Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Definition
1.2 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size and Forecast
1.2.1 By Consumption Value, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size，2019-2030
1.2.2 By Sales Quantity, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size，2019-2030
1.2.3 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Average Selling Price (ASP)，2019-20301.3 China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size and Forecast
1.3.1 By Consumption Value, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size，2019-2030
1.3.2 By Sales Quantity, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size，2019-2030
1.3.3 China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Average Selling Price (ASP)， 2019-20301.4 Share of China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market with Respect to the Global Market
1.4.1 By Consumption Value, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Share in Global, 2019-2030
1.4.2 By Sales Quantity, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Share in Global, 2019-2030
1.4.3 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size: China VS Global, 2019-20301.5 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Dynamics
1.5.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Drivers
1.5.2 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Restraints
1.5.3 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Industry Trends
1.5.4 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Industry Policy
2 Global Leading Manufacturers and Market Share2.1 By Revenue of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug, Global Market Share by Company, 2019-2024
2.2 By Sales Quantity of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug, Global Market Share by Company, 2019-2024
2.3 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Average Selling Price (ASP) by Company, 2019-2024
2.4 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Concentration Ratio
2.6 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Mergers & Acquisitions, Expansion Plans
2.7 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Manufacturers Product Type
2.8 Head Office and Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production Site of Key Manufacturer
2.9 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share3.1 By Revenue of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug, China Market Share by Company, 2019-2024
3.2 By Sales Quantity of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug, China Market Share by Company, 2019-2024
3.3 China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions4.1 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Capacity, Output and Capacity Utilization, 2019-2030
4.2 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Capacity by Region
4.3 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production & Forecast by Region, 2019 VS 2024 VS 2030
4.4 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production by Region, 2019-2030
4.5 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis5.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Industry Chain
5.2 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Upstream Analysis
5.2.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Core Raw Materials
5.2.2 Main Manufacturers of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Core Raw Materials5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production Mode
5.6 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Procurement Model
5.7 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Industry Sales Model and Sales Channels
5.7.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Model
5.7.2 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Typical Distributors
6 Sights by Type6.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Classification
6.1.1 Lipopeptide
6.1.2 Oxazolidinone
6.1.3 Tetracycline
6.1.4 Cephalosporin
6.1.5 Lipoglycopeptide
6.1.6 Folate Antagonist
6.1.7 Other6.2 By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value, 2019-2030
6.4 By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, 2019-2030
6.5 By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Average Selling Price (ASP), 2019-2030
7 Sights by Application7.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Segment by Application
7.1.1 Hospital
7.1.2 Specialist Clinic
7.1.3 Other7.2 By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value, 2019-2030
7.4 By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, 2019-2030
7.5 By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Price, 2019-2030
8 Sales Sights by Region8.1 By Region, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value, 2019 VS 2024 VS 2030
8.2 By Region, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value, 2019-2030
8.3 By Region, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, 2019-2030
8.4 North America
8.4.1 North America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug & Forecasts, 2019-2030
8.4.2 By Country, North America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size Market Share8.5 Europe
8.5.1 Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size Market Share8.6 Asia Pacific
8.6.1 Asia Pacific Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size Market Share
8.7 South America
8.7.1 South America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level9.1 By Country, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size & CAGR, 2019 VS 2024 VS 2030
9.2 By Country, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value, 2019-2030
9.3 By Country, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, 2019-2030
9.4 U.S.
9.4.1 U.S. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.4.2 By Type, U.S. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 20299.5 Europe
9.5.1 Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.5.2 By Type, Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 20299.6 China
9.6.1 China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.6.2 By Type, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.7.2 By Type, Japan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.8.2 By Type, South Korea Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.9.2 By Type, Southeast Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 20299.10 India
9.10.1 India Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.10.2 By Type, India Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.11.2 By Type, Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile10.1 Basilea Pharmaceutica Ltd
10.1.1 Basilea Pharmaceutica Ltd Company Information, Head Office, Market Area, and Industry Position
10.1.2 Basilea Pharmaceutica Ltd Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications, and Application
10.1.3 Basilea Pharmaceutica Ltd Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Basilea Pharmaceutica Ltd Company Profile and Main Business
10.1.5 Basilea Pharmaceutica Ltd Recent Developments10.2 The Medicines Company
10.2.1 The Medicines Company Company Information, Head Office, Market Area, and Industry Position
10.2.2 The Medicines Company Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications, and Application
10.2.3 The Medicines Company Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.2.4 The Medicines Company Company Profile and Main Business
10.2.5 The Medicines Company Recent Developments10.3 Theravance Biopharma
10.3.1 Theravance Biopharma Company Information, Head Office, Market Area, and Industry Position
10.3.2 Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications, and Application
10.3.3 Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Theravance Biopharma Company Profile and Main Business
10.3.5 Theravance Biopharma Recent Developments10.4 Allergan
10.4.1 Allergan Company Information, Head Office, Market Area, and Industry Position
10.4.2 Allergan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications, and Application
10.4.3 Allergan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Allergan Company Profile and Main Business
10.4.5 Allergan Recent Developments10.5 Merck & Co., Inc
10.5.1 Merck & Co., Inc Company Information, Head Office, Market Area, and Industry Position
10.5.2 Merck & Co., Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications, and Application
10.5.3 Merck & Co., Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Merck & Co., Inc Company Profile and Main Business
10.5.5 Merck & Co., Inc Recent Developments10.6 Pfizer, Inc
10.6.1 Pfizer, Inc Company Information, Head Office, Market Area, and Industry Position
10.6.2 Pfizer, Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications, and Application
10.6.3 Pfizer, Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Pfizer, Inc Company Profile and Main Business
10.6.5 Pfizer, Inc Recent Developments
11 Conclusion
12 Appendix12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources12.3 Market Estimation Model
12.4 Disclaimer
-
The Methicillin Resistant Staphylococcus Aureus Infection Treatment Drug Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Methicillin Resistant Staphylococcus Aureus Infection Treatment Drug Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
The Methicillin Resistant Staphylococcus Aureus Infection Treatment Drug Global and China Top Players Market is expected to reach a reasonable valuation by 2029; now the market is expected to shift its focus from growth to value.
As the shift to value addition continues, companies in the Methicillin Resistant Staphylococcus Aureus Infection Treatment Drug Global and China Top Players Market face the dual challenge of improving interoperability to optimize performance and experience.
Companies in the Methicillin Resistant Staphylococcus Aureus Infection Treatment Drug Global and China Top Players Industry are thoroughly researched and profiled in order to determine why certain trends will have a significant impact and how they will be factored into the Methicillin Resistant Staphylococcus Aureus Infection Treatment Drug Global and China Top Players Market's trajectory and future outlook.
